US FDA approves J&J's bladder cancer treatment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Johnson & Johnson (NYSE: JNJ) | Delayed: 254.34 -1.69 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $256.03 | 52 Week High | $126.07 | |||
| Open | $256.00 | 52 Week Low | $94.28 | |||
| Day High | $256.24 | P/E | 52.88 | |||
| Day Low | $253.34 | EPS | $4.81 | |||
| Volume | 1,736,243 | |||||
